Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology.
Baarsma, Hoeke A
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology. [electronic resource] - Respiratory research Oct 2013 - 113 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-993X
10.1186/1465-9921-14-113 doi
Animals
Collagen--metabolism
Disease Models, Animal
Enzyme Inhibitors--pharmacology
Fibronectins--metabolism
Glycogen Synthase Kinase 3--antagonists & inhibitors
Guinea Pigs
Indoles--pharmacology
Lipopolysaccharides--adverse effects
Lung--drug effects
Male
Maleimides--pharmacology
Muscle, Smooth--drug effects
Pulmonary Disease, Chronic Obstructive--chemically induced
Signal Transduction--drug effects
Smad Proteins--metabolism
beta Catenin--metabolism
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology. [electronic resource] - Respiratory research Oct 2013 - 113 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-993X
10.1186/1465-9921-14-113 doi
Animals
Collagen--metabolism
Disease Models, Animal
Enzyme Inhibitors--pharmacology
Fibronectins--metabolism
Glycogen Synthase Kinase 3--antagonists & inhibitors
Guinea Pigs
Indoles--pharmacology
Lipopolysaccharides--adverse effects
Lung--drug effects
Male
Maleimides--pharmacology
Muscle, Smooth--drug effects
Pulmonary Disease, Chronic Obstructive--chemically induced
Signal Transduction--drug effects
Smad Proteins--metabolism
beta Catenin--metabolism